Journals By Industry - Anti-Infectives

POC-W211 runs on an Intel Core i7 2655-LE 2.2 GHz processor and chipset capable of displaying crystal clear images on its 21.5 inches wide-screen display. The system is highly integrated and provides a...

KALYDECO is approved for people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was granted...

These activated hydrogen peroxide products are registered by the US Environmental Protection Agency, or EPA, as disinfectants, a requirement for any product labeled as a disinfectant. The company said that the Clorox Healthcare...

Tokyo, Jan 31, 2012 - (JCN) - In line with its commitment to support the World Health Organization's lymphatic filariasis elimination program, Eisai Co., Ltd, as one of the 13 major research and...

GS-7340 is a novel prodrug of tenofovir, the active agent in Viread, or tenofovir disoproxil fumarate. In previous studies, GS-7340 has demonstrated the ability to provide greater antiviral efficacy at a dose that...

RESEARCH TRIANGLE PARK, N.C. -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Nancy J. Hutson, Ph.D. was elected to the Company's Board of Directors, effective Friday, January 20, 2012. "We are excited to...

Stony Brook University has entered into a multiyear research partnership with the global pharmaceutical company Sanofi to develop a potential treatment for tuberculosis and other bacterial infections. The university didn't disclose the terms...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/c26efd/antifungals_market) has announced the addition of the "Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth" report to their...

Austin-based Local, Organic Food Delivery Company Expands Service to DFW Metroplex, Headquarters North Texas Operations in New Allen Local Food Hub DALLAS -- Greenling, a web-based home delivery service of fresh, local and...

Study also Demonstrated 100% Sustained Virologic Response 12-Weeks Post Treatment with Quadruple Therapy Phase II Investigational Data Published Today in the New England Journal of Medicine PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE:...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/df7978/antibiotic_resista) has announced the addition of the "Antibiotic Resistance 2012: The Antibiotic Development Pipeline and Strategies to Combat Antibiotic Resistance" report to their offering. This report gives a...

NEW YORK -- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share were $1.04 in the third quarter of fiscal 2012. Reported earnings per...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/8f5a37/dermatology_therap) has announced the addition of the "Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/e01e5a/influenza_vaccine) has announced the addition of the "Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast" report to their offering. Last few years have seen renewed interest in the...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/0a092f/antibotics_and_ant) has announced the addition of John Wiley and Sons Ltd's new book "Antibotics and Antibotic Resistance" to their offering. This book, which is the translated version of a...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/454d3a/product_profiles) has announced the addition of the "Product Profiles: Marketed Antibacterials - Increasing genericization and fragmentation shape a crowded market" report to their offering. In the last two...

Simple guidelines for increasing safety compliance in the workplace CINCINNATI -- In 2010, more than 3.9 million workplace injuries and illnesses were reported, many of which were preventable. No significant changes to these...

CAMBRIDGE, Mass. -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its fourth quarter and full year 2011 financial results on Thursday, February 2, 2012 after the financial markets close. The company will host...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/fea2f0/hepatitis_market_t) has announced the addition of the "Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market"...